Other potential targets for bone metastatic breast cancer could be the calcium sensing receptor (CaSR) and the bioactive lipids lysophosphatidic acid (LPA) and sphingosine 1-phospahte (S1P) [27,34]. This evidence concerns the gene CASR and breast carcinoma.